rfhg_127466.1

Basic information about the TSS

---

TSS ID: rfhg_127466.1 TSS ID(Version3): hg_105791.1 hg_105792.1 hg_105793.1 Species: human Chr: chr10		Start: 79347439 End: 79347540 Strand: +
Source datasets	FANTOM5|PRJNA401781|PRJNA548673|PRJNA615891|PRJNA4843412 |DRA013844
Protocol	CAGE|ReCappable-seq|SLIC_CAGE|TIF-seq2|NETCAGE
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2365959,EH38E1482710)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000498681.5:0 ENST00000472580.6:0 ENST00000225174.8:0 ENST00000492149.1:0 AK312757:0 AK296669:0 M80254:0 BC005020:0 BC013204:0 BC110299:0 GeneID: 10105 HGNC/MGI_ID: HGNC:9259 UniProt_ID: A0A024QZS4 B2R6X6 R4GN99 Nearer transcript ids and distances: AB529152:5 CU678858:9 HQ447889:9 EU831447:9 ENST00000448165.1:118 view more...

Gene_name: peptidylprolyl isomerase F Gene_symbol: PPIF Gene_synonyms: Cyp-D CypD hCyP3 Gene_source: HGNC:9259

TATA-Box annotation

---

Distance to TSS:	20
Nearest PromoterID:	NM_005729
Entrez ID:	10105
Nearest Unigene:	Hs.381072
Nearest Refseq:	NM_005729
Nearest Ensembl:	ENSG00000108179
Gene Name:	peptidylprolyl isomerase F
Gene Alias:	CYP3|CyP-M|Cyp-D|CypD
Gene Type:	protein-coding
CpG%:	0.168317
GC%:	0.705882
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PPIF p2@PPIF p3@PPIF p4@PPIF
Sample		p1@PPIF	p2@PPIF	p3@PPIF	p4@PPIF
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	261.82	13.05	27.86	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	256.54	10.93	23.87	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	269.87	12.54	19.29	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	263.84	11.64	20.38	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	291.56	10.12	27.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	286.65	8.72	19.57	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	335.76	14.16	24.40	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	358.97	13.08	28.58	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	386.40	16.03	28.85	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	324.59	7.54	16.81	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	314.49	8.49	16.98	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	325.65	5.29	19.92	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.47	5.96	5.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.56	4.66	3.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.49	4.83	3.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	29.17	6.04	5.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.23	4.15	6.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.57	3.37	4.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	5.86	4.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.84	3.46	2.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.60	4.14	4.95	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.32	3.63	5.01	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.21	4.91	6.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	32.76	6.31	5.82	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	35.86	5.68	5.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.51	4.75	4.43	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.36	5.49	6.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	6.37	4.95	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.63	4.36	5.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	35.47	3.62	5.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	37.89	3.98	4.61	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.17	3.71	4.10	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.92	4.43	5.91	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.57	4.62	5.61	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.28	5.24	5.80	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.90	4.79	4.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.47	3.07	4.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.64	4.43	6.25	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.55	5.13	2.43	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	27.85	3.36	5.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.29	3.76	4.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.13	3.07	6.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.78	6.33	2.74	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.97	3.67	4.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.90	5.42	4.22	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.73	4.42	3.02	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	32.15	5.28	8.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.27	2.09	6.86	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	28.25	4.31	5.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.04	2.43	3.03	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.57	2.46	5.33	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.02	6.00	5.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	29.10	6.03	6.03	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.13	7.29	6.63	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	2.52	5.03	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	3.67	2.30	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	52.18	5.51	8.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.50	6.74	8.67	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.46	2.20	4.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	7.05	9.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.09	5.61	5.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.73	2.72	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.24	5.85	3.90	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	36.21	6.03	4.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	30.23	4.88	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.29	3.97	4.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	2.81	4.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.86	1.32	2.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	28.77	4.02	3.40	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.85	4.28	4.89	0.00
Adipocyte - breast, donor1	11376-118A8	24.87	8.24	7.13	0.00
Adipocyte - breast, donor2	11327-117E4	137.81	12.99	11.71	1.44
Adipocyte - omental, donor1	11473-119C6	43.26	9.67	7.63	0.13
Adipocyte - omental, donor2	11474-119C7	35.13	4.48	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	99.81	14.40	8.04	0.67
Adipocyte - perirenal, donor1	11476-119C9	28.07	11.48	4.47	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	67.07	13.19	11.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	53.74	13.55	9.94	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	115.21	19.64	17.03	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	114.80	15.06	12.71	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	137.96	10.55	10.55	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	100.92	11.15	13.10	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	104.63	7.05	12.93	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	227.95	25.26	23.49	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	152.02	13.23	14.85	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	157.82	6.40	17.06	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	173.05	15.58	13.91	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	271.16	37.43	31.19	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	179.08	14.32	15.32	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	232.02	16.69	20.62	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	220.44	27.71	25.58	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	67.85	11.93	12.15	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	113.67	18.65	15.06	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	31.15	5.99	9.58	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.21	6.30	4.32	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	8.37	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.97	4.73	4.52	0.21
Anulus Pulposus Cell, donor1	11248-116E6	27.92	7.90	8.47	0.23
Anulus Pulposus Cell, donor2	11463-119B5	42.61	8.82	6.37	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	63.35	10.78	8.99	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	65.56	8.25	6.51	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	64.21	8.56	6.42	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	63.07	6.88	7.47	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	54.38	3.79	5.06	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.09	9.24	3.30	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	66.60	8.45	5.85	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	71.36	8.25	9.22	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	57.01	7.72	6.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	57.63	10.92	12.81	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	77.65	7.26	7.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	61.44	13.79	5.02	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	48.43	10.05	8.40	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	15.01	12.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	55.94	6.94	5.88	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	53.58	12.32	8.04	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	71.61	9.64	7.75	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	61.48	9.62	10.69	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	79.99	6.83	7.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	53.41	8.96	7.30	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	57.63	9.61	6.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	67.26	10.62	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.12	6.86	10.81	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	54.53	20.97	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	55.82	9.22	9.22	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	44.02	4.55	3.42	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	13.33	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	57.57	6.27	8.55	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.46	11.12	6.20	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	36.91	8.26	6.19	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	48.33	9.38	5.16	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	63.99	10.61	7.40	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	54.22	7.85	5.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	55.57	5.85	8.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	56.90	7.23	7.83	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	62.96	9.50	5.94	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	64.08	5.59	3.56	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.03	5.60	7.64	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	64.17	8.90	5.08	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	54.80	10.36	7.34	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.92	9.53	5.93	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	64.96	9.86	6.38	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	77.47	15.12	5.67	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	57.47	9.49	7.29	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	81.07	0.00	11.58	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	76.05	10.56	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	87.48	8.15	8.79	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	71.00	10.23	6.02	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	90.39	5.83	5.83	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	72.41	8.05	5.98	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	81.61	7.65	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	91.27	12.97	9.41	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	94.55	8.05	7.84	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	75.58	7.34	7.34	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	77.44	12.91	7.17	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	69.63	9.09	9.31	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	70.19	4.58	10.68	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	88.07	8.86	8.31	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	77.32	11.12	6.62	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	87.23	10.18	7.27	1.09
Astrocyte - cerebellum, donor1	11500-119F6	74.30	21.12	15.72	0.00
Astrocyte - cerebellum, donor2	11580-120F5	71.37	19.68	11.98	0.34
Astrocyte - cerebellum, donor3	11661-122F5	66.07	9.23	10.28	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	25.10	14.64	8.37	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	49.66	16.18	15.37	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	50.42	16.56	13.72	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	158.04	16.97	30.74	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	192.56	23.93	38.71	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	155.33	18.78	31.64	0.00
Basophils, donor1	12241-129G9	257.09	24.58	17.52	0.52
Basophils, donor2	12242-129H1	249.67	26.34	19.12	0.36
Basophils, donor3	12243-129H2	477.15	44.54	49.10	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	61.66	7.98	6.47	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	70.41	14.63	5.49	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	85.36	9.41	11.30	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	108.76	13.52	13.10	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	47.67	7.37	3.91	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	72.70	8.46	4.50	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	90.79	17.00	17.52	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	187.49	24.92	29.35	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	70.99	17.59	15.99	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	382.09	30.43	31.00	0.00
CD14+ Monocytes, donor2	11305-117B9	541.95	45.29	35.26	1.11
CD14+ Monocytes, donor3	11381-118B4	462.12	44.57	33.81	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.74	11.32	5.94	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	8.34	7.96	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	8.55	8.55	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	1113.61	18.36	24.43	6.22
CD14+ monocytes - mock treated, donor2	11873-125C1	1490.61	16.90	20.22	4.22
CD14+ monocytes - mock treated, donor3	11883-125D2	1482.24	18.24	18.00	3.55
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1776.76	15.74	26.45	5.19
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2295.59	18.77	17.11	7.45
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3101.84	14.88	22.07	9.92
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2777.82	14.29	16.25	12.14
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2514.58	14.60	21.19	11.22
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2830.93	19.15	15.67	15.02
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1441.05	10.30	24.82	4.45
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1656.95	20.07	29.04	5.81
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2273.07	22.19	23.30	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1790.49	22.01	26.63	10.56
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2232.14	18.96	18.56	7.98
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1942.50	14.37	16.03	8.33
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2134.79	15.10	23.79	9.61
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1723.67	13.57	17.42	3.17
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2338.12	13.53	15.71	10.04
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1214.76	16.95	22.60	5.11
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1746.87	22.68	28.96	5.58
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1801.11	26.09	20.62	8.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1095.28	6.43	10.47	4.41
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1499.24	9.16	10.92	4.93
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1550.89	8.34	9.21	3.51
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2313.94	14.47	24.76	10.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2410.70	20.81	23.04	12.27
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2403.16	14.44	23.28	6.68
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	728.48	7.78	9.83	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1013.19	4.87	6.26	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1058.12	7.89	9.28	3.48
CD14+CD16+ Monocytes, donor1	11789-124B7	50.13	17.87	7.19	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	106.49	24.25	15.01	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	90.11	18.41	9.75	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	157.59	37.84	29.12	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	134.65	35.80	28.82	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	89.86	21.63	16.50	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	32.92	11.74	6.38	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	19.76	10.76	4.17	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	24.00	10.74	4.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	4.06	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	4.75	7.46	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	7.25	5.18	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	10.66	5.33	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	8.04	3.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	5.62	6.32	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.12	7.06	6.27	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	19.77	10.55	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	60.82	13.97	9.04	0.00
CD19+ B Cells, donor2	11624-122B4	129.85	30.47	15.96	0.00
CD19+ B Cells, donor3	11705-123B4	80.27	21.20	15.65	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	21.42	17.78	5.66	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	32.76	15.58	5.99	0.00
CD34+ Progenitors, donor1	11545-120B6	43.17	11.04	8.03	0.00
CD34+ Progenitors, donor2	11625-122B5	106.18	11.80	12.36	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	92.44	18.41	16.91	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	88.39	15.56	16.69	0.23
CD4+ T Cells, donor1	11225-116C1	15.71	13.21	6.78	0.00
CD4+ T Cells, donor2	11306-117C1	33.68	18.98	4.90	0.61
CD4+ T Cells, donor3	11382-118B5	30.19	14.03	6.71	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	17.87	10.21	7.40	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	23.36	14.82	10.33	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.26	8.62	11.79	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	10.43	4.74	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.75	9.13	7.73	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.61	11.71	6.36	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	47.45	16.44	9.15	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	44.17	16.12	12.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.45	5.38	4.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	12.58	11.18	7.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	8.80	5.72	3.08	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.24	17.71	10.96	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	43.01	16.00	11.64	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.10	16.04	9.02	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.34	6.25	2.72	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6.43	4.29	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	7.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	41.54	18.36	10.94	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	49.17	14.73	8.88	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	59.05	13.87	14.29	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	12.13	4.55	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.13	10.83	7.80	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.90	4.79	2.61	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	15.84	6.93	5.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	4.62	3.69	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	6.98	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	28.80	10.25	4.43	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	16.93	5.64	3.19	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	4.62	7.70	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.05	8.95	3.58	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	9.69	5.54	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	24.88	13.75	8.18	0.00
CD8+ T Cells, donor2	11307-117C2	35.67	12.76	5.26	0.38
CD8+ T Cells, donor3	11383-118B6	28.53	12.62	6.56	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	158.51	8.26	14.68	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	144.74	10.78	12.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	131.32	8.75	15.59	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	164.82	8.11	13.51	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	174.47	8.40	15.84	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	157.35	10.23	15.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	162.31	9.78	16.73	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	169.77	10.53	13.42	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	156.66	13.37	11.26	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	180.52	15.40	19.02	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	160.36	15.40	12.20	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	195.03	11.99	14.12	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	136.14	7.88	8.76	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	144.83	9.56	5.47	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	163.35	13.43	8.20	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	195.56	11.89	15.49	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	176.37	9.21	16.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	147.07	10.61	12.26	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	192.36	14.89	14.89	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	187.31	12.30	11.99	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	167.99	9.62	10.58	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	161.02	10.71	12.62	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	145.42	10.25	11.03	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	142.21	8.32	9.08	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	172.64	4.82	11.24	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	155.97	6.99	6.99	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	212.37	10.02	7.01	0.00
Cardiac Myocyte, donor1	11525-119I4	73.11	18.28	12.79	0.00
Cardiac Myocyte, donor2	11605-120I3	60.28	15.81	14.82	0.49
Cardiac Myocyte, donor3	11686-122I3	30.20	7.79	8.73	0.00
Chondrocyte - de diff, donor1	11261-116G1	38.48	10.75	7.28	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.55	4.26	3.91	0.00
Chondrocyte - de diff, donor3	11410-118E6	35.04	7.74	4.78	0.23
Chondrocyte - re diff, donor2	11339-117F7	13.43	3.58	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	35.99	4.04	6.87	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	24.79	9.18	10.56	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	25.01	5.77	7.70	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	30.35	8.76	7.79	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	45.48	13.94	9.90	0.00
Corneal Epithelial Cells, donor1	11526-119I5	77.95	9.00	7.47	0.00
Corneal Epithelial Cells, donor2	11606-120I4	54.60	11.38	6.83	0.00
Corneal Epithelial Cells, donor3	11687-122I4	113.24	11.50	8.69	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	48.21	5.78	4.29	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	52.36	4.73	6.31	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	62.20	4.86	4.21	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	58.76	14.69	12.30	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	63.33	22.20	13.06	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	34.84	16.45	3.87	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	19.18	5.34	4.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	40.49	8.21	8.80	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	19.23	8.48	5.94	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	15.73	6.29	9.83	0.00
Endothelial Cells - Artery, donor1	11264-116G4	27.05	10.47	7.27	0.00
Endothelial Cells - Artery, donor2	11341-117F9	38.35	12.71	6.82	0.00
Endothelial Cells - Artery, donor3	11413-118E9	41.90	12.62	8.06	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	5.32	3.55	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.91	5.78	4.56	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.84	3.10	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	16.05	8.32	5.05	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	9.37	6.25	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	13.04	4.11	5.25	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	51.62	19.21	8.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	22.54	5.24	6.81	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.88	15.03	11.68	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	32.81	8.91	8.91	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.86	9.89	13.68	0.00
Endothelial Cells - Vein, donor1	11267-116G7	46.64	7.96	12.51	1.14
Endothelial Cells - Vein, donor2	11344-117G3	20.96	9.78	11.18	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.46	8.64	8.79	0.00
Eosinophils, donor1	12244-129H3	30.49	30.49	15.25	0.00
Eosinophils, donor2	12245-129H4	1280.60	95.72	118.82	0.00
Eosinophils, donor3	12246-129H5	1523.03	49.94	74.90	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	46.91	8.80	4.89	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	64.49	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	23.40	6.57	4.93	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.85	9.53	7.77	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	45.72	7.37	6.50	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.68	8.13	9.58	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.13	7.10	6.69	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	50.63	9.60	8.33	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	40.05	4.74	5.27	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	50.16	9.97	11.63	0.00
Fibroblast - Cardiac, donor1	11268-116G8	50.35	9.07	5.90	0.45
Fibroblast - Cardiac, donor2	11345-117G4	36.38	6.06	6.06	0.00
Fibroblast - Cardiac, donor3	11417-118F4	26.34	6.62	7.57	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.31	9.09	12.73	0.00
Fibroblast - Cardiac, donor5	11456-119A7	40.48	11.55	6.60	0.00
Fibroblast - Cardiac, donor6	11460-119B2	64.58	13.95	9.25	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.47	14.07	7.24	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	68.60	6.04	9.06	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	67.38	7.32	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	52.82	7.84	10.61	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	27.48	9.67	7.46	0.17
Fibroblast - Dermal, donor1	11269-116G9	117.86	15.50	13.85	0.23
Fibroblast - Dermal, donor2	11346-117G5	91.98	16.98	13.68	0.00
Fibroblast - Dermal, donor3	11418-118F5	91.39	16.92	14.63	0.60
Fibroblast - Dermal, donor4	11450-119A1	83.20	14.47	13.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	114.96	15.70	17.62	0.52
Fibroblast - Dermal, donor6	11458-119A9	134.97	21.12	15.59	0.32
Fibroblast - Gingival, donor1	11237-116D4	37.48	7.91	6.66	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.39	4.45	4.98	0.00
Fibroblast - Gingival, donor2	11318-117D4	89.35	12.65	11.20	0.26
Fibroblast - Gingival, donor3	11394-118C8	45.93	8.12	5.51	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	83.11	10.39	5.19	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	86.16	6.34	7.93	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	142.18	13.10	13.41	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	103.99	8.52	7.98	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	260.78	8.82	14.82	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	78.09	7.75	6.14	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	73.49	7.36	6.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	162.57	11.30	7.35	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.69	3.23	5.58	0.00
Fibroblast - Lung, donor1	11270-116H1	31.27	14.95	10.87	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	17.91	8.95	0.00
Fibroblast - Lung, donor3	11419-118F6	69.43	18.57	19.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	78.30	31.65	8.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	79.72	16.78	8.39	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	52.62	13.99	8.68	0.00
Fibroblast - Mammary, donor1	11540-120B1	90.53	24.76	19.49	0.00
Fibroblast - Mammary, donor2	11620-122A9	91.87	19.97	15.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	83.39	0.00	29.78	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	49.08	11.06	12.03	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	68.56	13.04	13.04	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	50.79	7.65	14.08	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	69.84	6.49	7.25	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	92.88	6.21	8.10	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	104.14	6.61	8.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	48.86	12.27	10.50	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	66.85	13.41	13.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	108.25	19.38	11.36	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	57.72	9.88	8.30	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	72.23	7.94	6.35	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.98	4.62	3.02	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	41.98	8.87	6.70	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	46.33	4.21	4.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	40.27	6.15	4.75	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	45.05	6.58	5.06	0.25
Fibroblast - skin normal, donor1	11553-120C5	21.49	6.56	4.59	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.89	6.42	7.22	0.20
Fibroblast - skin normal, donor2	11561-120D4	25.32	5.22	5.22	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	54.70	4.23	8.76	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.44	6.05	4.97	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.17	8.03	3.76	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	27.26	5.25	2.96	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.74	6.39	5.22	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	78.10	6.07	7.42	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.62	2.67	3.29	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	72.34	9.59	6.10	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	234.38	8.32	11.09	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	176.44	7.03	9.11	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	199.30	6.64	8.43	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	97.99	13.01	16.84	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	84.86	11.49	11.49	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	85.01	5.71	8.84	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	39.16	5.24	7.17	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	53.20	3.65	8.68	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	84.60	7.93	12.09	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	38.59	6.61	12.16	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	65.56	8.48	5.87	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	55.28	3.54	5.75	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	73.20	7.35	13.71	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.97	8.87	15.02	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	84.35	9.13	17.19	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	78.80	9.42	14.25	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	74.75	9.55	13.29	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	75.02	9.76	13.01	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	67.31	12.32	9.36	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	63.03	7.60	9.84	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	64.04	6.12	9.84	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	58.21	11.52	13.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.87	12.24	14.31	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	68.59	11.17	8.94	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.84	16.94	11.09	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.62	15.44	16.12	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.56	12.86	12.86	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.45	14.26	16.02	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	40.13	11.10	10.76	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	51.56	12.39	13.72	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.17	14.81	13.48	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.17	11.43	9.60	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.77	9.90	11.76	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	47.39	13.26	10.26	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	58.53	13.84	13.01	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	47.17	10.80	13.23	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.23	12.30	14.39	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	61.60	15.40	13.29	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	45.22	11.23	12.19	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.52	11.94	10.23	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	53.94	11.23	13.13	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.18	9.43	12.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	33.03	12.02	9.20	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.64	10.54	8.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	10.66	9.54	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	44.53	10.37	10.65	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	63.37	12.84	17.38	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	71.76	11.32	11.78	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	65.16	12.44	14.77	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.94	13.28	13.55	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.18	9.22	7.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.07	10.97	7.68	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	8.93	12.89	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.98	6.46	7.91	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.61	8.07	6.66	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	22.62	9.91	9.66	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	57.93	6.57	9.36	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	73.65	9.24	13.25	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	88.58	9.62	13.09	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	82.93	12.83	14.39	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	106.24	11.87	15.26	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	93.62	13.84	14.30	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	98.99	12.37	7.42	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	95.54	9.28	11.99	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	113.92	17.65	19.25	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	86.94	19.13	22.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	68.68	12.04	14.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	71.24	9.47	13.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	10.00	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.23	10.07	17.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	78.12	5.88	13.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	16.78	16.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	79.52	12.09	10.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	72.01	9.51	13.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	10.44	20.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	75.60	13.17	18.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.60	13.62	11.84	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	67.77	8.47	16.94	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	75.80	9.53	16.57	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	65.59	12.20	10.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	0.00	21.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.82	11.53	13.07	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	64.22	12.06	10.43	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	82.27	14.05	14.71	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.49	15.03	13.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	100.31	14.72	18.49	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	14.91	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	63.23	16.99	14.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	87.51	13.28	13.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	65.62	15.77	11.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.20	17.95	15.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	58.22	9.37	16.28	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	96.80	9.44	16.53	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	69.43	13.42	12.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.39	14.48	9.22	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	60.19	14.41	16.95	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	72.23	19.10	19.70	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	59.69	11.16	14.56	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	124.40	5.71	12.55	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.30	13.31	5.82	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	113.57	15.74	11.24	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	69.78	10.47	8.56	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	48.04	10.86	10.86	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	99.80	19.26	16.13	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	111.07	20.76	14.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	113.52	17.52	12.74	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	102.09	16.51	17.71	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	105.95	17.41	13.54	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	109.36	20.67	12.70	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	98.26	19.30	13.95	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	98.30	15.27	9.61	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	95.79	10.89	10.25	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	38.05	11.75	5.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	87.42	9.95	10.39	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	10.58	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	37.74	11.64	7.76	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	49.40	15.98	5.09	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.18	11.71	7.87	0.17
Hepatocyte, donor1	11523-119I2	165.85	20.58	12.11	1.21
Hepatocyte, donor2	11603-120I1	328.59	33.40	20.47	0.00
Hepatocyte, donor3	11684-122I1	84.05	17.79	15.95	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	52.21	11.75	7.18	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	58.03	12.23	6.12	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.95	7.41	7.96	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	299.29	28.66	38.21	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	186.91	13.35	53.40	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	270.83	0.00	135.42	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	346.09	31.84	41.53	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	172.68	17.52	32.53	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	486.60	23.74	71.21	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	343.43	38.44	84.58	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	173.69	22.85	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	332.99	40.61	34.11	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	296.78	23.34	30.01	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	112.55	29.04	39.94	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	363.95	35.73	46.32	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	262.75	27.72	42.13	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	157.15	36.67	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	255.72	29.60	29.60	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	255.19	24.75	41.76	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	248.79	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	233.87	30.36	49.10	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	252.76	30.59	43.47	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	286.76	23.90	47.79	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	250.17	35.04	39.93	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	187.24	34.42	42.82	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	229.96	28.74	43.12	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	245.12	36.97	41.79	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	254.83	36.01	30.47	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	196.05	60.32	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	229.88	33.51	49.56	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	243.98	27.21	37.19	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	191.65	29.48	58.97	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	271.18	30.13	37.66	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	321.43	34.30	43.20	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	197.16	32.86	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	246.78	26.14	29.97	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	309.85	32.81	38.28	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	173.85	0.00	31.61	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	253.49	32.13	37.13	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	328.51	23.23	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	416.97	20.85	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	272.24	40.43	49.08	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	324.86	24.58	40.39	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	367.75	50.29	40.86	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	266.33	34.77	51.46	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	212.46	37.62	48.69	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	213.97	22.69	45.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	163.05	25.29	39.24	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	143.99	29.25	40.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	167.26	27.88	27.88	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	172.82	37.34	42.67	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	245.22	40.18	40.18	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	293.51	31.35	39.89	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	218.14	44.18	41.42	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	148.24	21.18	51.43	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	117.96	31.04	31.04	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	125.83	29.61	32.78	3.17
Keratinocyte - epidermal, donor1	11272-116H3	107.55	6.77	6.45	0.16
Keratinocyte - epidermal, donor2	11349-117G8	62.66	5.27	5.86	0.00
Keratinocyte - epidermal, donor3	11421-118F8	140.75	9.37	8.71	0.28
Keratinocyte - oral, donor1	11251-116E9	67.66	11.58	9.99	0.45
Keratocytes, donor1	11527-119I6	87.33	17.19	13.41	0.00
Keratocytes, donor2	11607-120I5	86.71	19.92	12.89	0.00
Keratocytes, donor3	11688-122I5	65.21	10.47	8.89	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	2.20	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	50.70	9.71	9.71	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.37	5.54	10.61	0.00
Lens Epithelial Cells, donor3	11690-122I7	11.81	3.94	4.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.53	5.57	7.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.79	7.54	6.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.70	6.61	5.67	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	5.38	5.91	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	31.83	3.47	5.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.98	5.61	6.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	3.28	5.75	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	46.77	4.80	7.08	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.01	7.04	7.18	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	32.83	2.37	5.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	49.25	5.43	4.85	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.22	6.67	6.67	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.83	5.23	7.67	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	46.04	8.83	5.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	30.90	8.24	5.77	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.35	5.85	6.78	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	44.27	6.86	7.17	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	34.95	7.87	9.70	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	3.62	6.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	48.32	5.56	5.86	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	35.60	5.73	10.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	33.46	3.88	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	58.98	4.58	8.89	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	24.07	7.72	8.33	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	34.22	5.18	4.67	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.53	5.65	6.28	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.23	6.62	8.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.96	4.13	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.33	6.40	6.40	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.10	6.89	7.32	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	36.83	3.88	4.85	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.31	3.31	5.62	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.39	7.68	6.94	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.14	5.92	7.03	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.75	7.91	5.44	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.87	7.15	7.01	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.66	4.82	5.15	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	48.08	5.48	5.48	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	29.95	7.00	5.88	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	4.98	6.40	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.15	7.27	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	30.34	7.16	6.07	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	38.68	5.01	7.88	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	48.35	8.82	7.84	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	28.72	8.00	8.48	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	26.73	6.56	6.56	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.90	6.66	5.89	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	38.19	5.97	8.65	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	95.17	6.80	11.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	128.11	9.97	9.21	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	119.50	9.65	12.62	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	141.75	22.00	7.62	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	172.31	11.25	10.55	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	139.16	15.88	7.47	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	129.33	12.37	6.70	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	135.60	13.08	7.14	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	111.06	14.93	11.31	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	137.27	11.05	8.14	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	144.96	12.15	9.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	123.83	14.36	12.87	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	161.25	15.92	10.27	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	157.02	13.06	8.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	158.58	12.66	10.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	156.38	17.32	6.11	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	150.75	11.47	9.87	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	154.56	14.93	11.53	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	152.78	11.04	10.43	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	164.72	15.49	6.52	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	136.40	12.08	8.95	2.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	138.17	10.93	8.13	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	149.40	12.36	10.30	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	163.15	16.26	10.16	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	139.30	15.84	8.07	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	151.59	11.62	9.41	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	169.32	12.02	7.78	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	135.71	14.38	10.69	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	134.70	14.97	11.51	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	170.39	14.58	6.52	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	109.83	12.45	5.10	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	138.66	13.95	9.03	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	147.31	16.27	8.59	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	117.78	12.21	9.34	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	155.36	13.44	12.70	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	130.80	11.52	8.92	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	108.55	16.37	6.03	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	115.60	11.13	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	133.94	10.99	6.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	112.22	13.88	9.05	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	132.96	12.80	4.98	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	128.55	9.28	6.53	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	97.69	12.35	8.05	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	115.82	8.08	4.71	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	138.90	8.52	8.89	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	88.38	9.30	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	131.16	5.29	7.40	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	135.65	10.40	8.80	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	130.84	13.81	11.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	164.80	20.70	10.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	164.26	12.83	8.39	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	137.38	6.59	6.59	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	175.99	17.60	12.57	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	139.69	11.72	7.66	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	129.08	20.65	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	155.42	12.47	5.79	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	162.28	14.08	10.17	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	131.95	13.19	5.28	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	163.46	16.61	11.94	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	183.78	12.69	10.94	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	154.87	10.06	7.83	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	184.16	13.69	5.74	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	165.09	17.74	10.80	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	148.87	14.18	5.57	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	204.74	14.90	12.98	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	182.08	10.73	9.94	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	162.84	12.15	8.51	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	172.23	14.53	10.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	185.82	9.88	11.40	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	155.96	10.84	10.33	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	192.28	15.72	7.86	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	173.98	10.77	10.46	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	176.99	16.53	7.46	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	189.07	18.39	10.34	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	187.70	19.54	4.63	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	176.84	15.56	10.61	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	203.73	13.05	12.48	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	189.71	10.82	5.41	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	159.74	11.75	9.40	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	205.43	12.94	6.26	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	197.94	12.55	6.97	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	147.19	10.70	10.04	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	207.98	12.83	9.62	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	185.08	12.53	11.72	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	160.61	11.01	12.85	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	160.04	16.89	7.11	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	174.95	8.55	7.98	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	141.88	12.27	6.14	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	149.38	9.85	6.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	157.24	7.57	5.79	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	102.68	11.44	7.80	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	177.05	8.62	5.97	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	241.12	10.39	10.39	0.00
Macrophage - monocyte derived, donor1	11232-116C8	57.89	6.84	4.79	0.00
Macrophage - monocyte derived, donor2	11313-117C8	93.77	4.40	5.69	0.00
Macrophage - monocyte derived, donor3	11389-118C3	159.79	9.57	5.90	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	216.13	10.09	7.97	0.00
Mallassez-derived cells, donor2	11929-125I3	93.01	6.02	4.12	0.32
Mallassez-derived cells, donor3	11930-125I4	119.67	7.64	7.92	0.14
Mammary Epithelial Cell, donor1	11273-116H4	43.44	6.58	8.07	0.00
Mammary Epithelial Cell, donor2	11350-117G9	48.64	8.69	4.34	0.00
Mammary Epithelial Cell, donor3	11422-118F9	45.40	15.46	10.48	0.00
Mast cell - stimulated, donor1	11487-119E2	3.39	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	11.46	2.49	4.33	0.00
Mast cell, donor2	11565-120D8	56.46	4.46	6.24	0.00
Mast cell, donor3	11566-120D9	58.08	15.98	10.81	0.23
Mast cell, donor4	11567-120E1	43.08	4.79	4.25	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	14.42	1.77	3.66	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	1.75	4.09	0.00
Mast cell, expanded, donor5	11939-126A4	14.68	2.52	3.56	0.11
Mast cell, expanded, donor8	11941-126A6	34.14	7.53	5.86	0.00
Melanocyte - dark, donor1	11502-119F8	19.10	7.26	7.66	0.00
Melanocyte - dark, donor2	11582-120F7	61.60	8.31	13.15	0.00
Melanocyte - dark, donor3	11663-122F7	66.07	16.81	19.70	0.36
Melanocyte - light, donor1	11274-116H5	29.62	5.17	6.58	0.00
Melanocyte - light, donor2	11351-117H1	24.57	10.92	11.60	0.00
Melanocyte - light, donor3	11423-118G1	44.23	11.27	6.94	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	75.49	15.31	14.37	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	51.37	15.06	13.45	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	85.18	14.20	11.79	0.27
Meningeal Cells, donor1	11493-119E8	89.45	25.68	12.53	0.00
Meningeal Cells, donor2	11573-120E7	109.60	24.21	13.64	0.00
Meningeal Cells, donor3	11654-122E7	72.45	17.77	18.50	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	47.91	11.41	9.41	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.94	5.43	4.43	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	32.85	14.46	6.57	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	122.97	22.24	10.47	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	141.37	20.09	23.68	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.39	4.87	5.93	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	38.20	9.05	2.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	104.16	16.26	18.02	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	119.82	19.73	12.42	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	131.15	18.82	17.19	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	51.66	12.33	5.68	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	59.10	12.64	8.55	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.21	9.34	7.11	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	83.68	10.68	8.31	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	58.39	9.34	7.01	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	103.74	18.57	12.81	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	94.64	14.53	18.79	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	9.69	8.44	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	137.88	16.69	25.40	0.00
Mesothelial Cells, donor1	11247-116E5	40.31	10.34	7.42	0.00
Mesothelial Cells, donor2	12156-128G5	24.02	7.01	3.50	0.00
Mesothelial Cells, donor3	11402-118D7	36.28	8.67	5.42	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	4.05	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	94.57	11.08	8.13	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	133.10	10.01	10.60	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	117.54	10.37	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	69.12	6.20	4.03	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	99.98	10.99	6.85	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	83.38	16.21	6.95	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	104.61	6.76	7.51	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	117.77	10.24	5.59	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	291.99	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	96.32	7.52	7.32	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	134.63	9.11	7.13	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	92.03	4.42	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	126.52	9.12	7.60	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	86.85	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	87.01	4.03	4.88	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	122.47	8.29	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	87.63	4.47	4.47	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	93.89	8.38	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	83.80	5.27	3.51	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	74.39	4.75	5.47	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	74.64	2.21	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	82.66	1.61	5.53	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	80.77	4.42	6.52	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	110.27	4.48	4.28	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	84.53	3.65	4.08	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	75.58	4.45	2.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	227.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	101.40	3.72	6.13	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	75.03	7.60	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	217.07	9.94	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	178.30	1.09	7.88	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	87.05	6.18	4.12	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	186.45	5.45	10.90	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	284.49	5.29	8.17	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	82.45	8.40	7.20	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	153.58	4.11	6.86	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	366.42	6.01	8.01	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	296.42	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	150.85	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	299.10	11.82	9.20	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	126.92	8.83	6.62	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	163.30	6.40	6.40	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	277.17	7.69	8.18	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	121.78	5.57	6.26	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	229.83	4.42	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	206.84	3.42	7.18	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	171.11	7.88	5.69	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	156.24	5.33	7.10	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	207.05	7.01	6.73	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	186.62	6.23	7.07	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	149.18	6.99	5.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	184.92	7.54	11.46	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	205.36	5.01	6.26	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	259.88	7.22	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	173.63	11.08	9.24	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	225.37	7.40	7.97	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	139.43	5.53	6.49	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	154.97	3.11	8.81	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	220.49	3.43	7.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	146.73	2.54	7.62	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	154.53	5.07	6.94	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	305.91	8.38	4.79	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	151.57	5.79	5.93	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	206.08	3.82	9.56	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	249.21	6.86	8.62	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	162.30	3.03	7.96	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	184.38	5.11	7.10	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	349.53	4.92	8.36	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	148.58	9.78	7.17	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	206.70	4.70	8.23	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	382.61	6.92	9.51	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	94.38	5.36	6.18	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	174.80	5.96	2.68	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	131.84	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	98.02	14.26	7.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	102.51	9.20	11.50	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	130.44	8.42	7.36	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	64.25	6.13	7.12	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	113.62	5.59	8.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	57.08	7.51	3.76	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	92.15	7.19	3.73	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	144.09	6.11	6.33	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	111.98	7.37	7.37	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	127.15	7.33	8.06	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	182.00	4.67	10.89	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	136.82	6.95	6.41	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	139.10	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	167.65	11.11	11.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	150.95	6.32	5.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	92.61	2.72	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	16.53	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	15.39	1.62	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	80.05	4.53	7.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	605.28	5.71	11.42	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	215.32	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	161.58	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	338.82	25.10	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	4.96	4.74	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	5.23	2.61	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	65.41	11.35	12.68	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	83.06	14.19	12.10	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	29.66	3.80	5.13	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	43.09	9.58	11.17	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	35.36	5.44	5.44	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	44.36	12.14	12.14	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	71.59	9.99	9.30	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.43	7.57	9.19	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.27	5.47	5.68	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	8.44	4.47	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.15	4.06	3.79	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	41.26	8.84	9.29	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	45.07	11.27	9.14	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	36.63	6.74	4.74	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	36.07	8.49	7.96	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	40.22	12.61	9.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	0.66	2.63	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	54.32	8.78	10.73	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	38.63	8.29	8.47	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	43.60	8.44	8.44	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	63.90	8.27	9.19	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	63.30	11.89	15.75	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.38	1.38	3.10	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	7.59	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.00	7.57	5.79	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.04	6.77	12.28	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	35.37	2.85	4.27	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	44.64	12.88	7.73	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.66	8.66	2.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	55.46	6.76	5.41	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	31.35	10.32	4.76	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	67.79	14.86	4.64	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	25.35	4.16	4.54	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	45.95	10.43	7.17	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.58	8.28	6.10	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	3.62	4.98	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	32.63	5.29	6.17	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	57.18	9.97	7.31	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	32.24	8.43	7.94	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	34.07	12.63	5.74	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	2.42	3.93	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.85	5.08	4.64	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	36.59	16.94	9.49	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	38.41	6.71	7.32	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.01	3.15	2.52	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	32.38	3.93	4.84	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	5.54	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	48.45	9.07	8.82	0.25
Myoblast, donor2	11322-117D8	47.56	10.36	7.48	0.58
Myoblast, donor3	11398-118D3	27.75	5.89	6.05	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	184.02	16.49	11.53	0.00
Natural Killer Cells, donor1	11230-116C6	50.74	16.30	9.23	0.00
Natural Killer Cells, donor2	11311-117C6	42.52	14.78	8.14	0.60
Natural Killer Cells, donor3	11387-118C1	64.60	16.93	13.62	0.74
Neural stem cells, donor1	11275-116H6	20.32	17.42	10.53	1.09
Neural stem cells, donor2	11352-117H2	17.33	15.41	13.48	0.00
Neurons, donor1	11494-119E9	29.59	10.24	11.38	3.41
Neurons, donor2	11574-120E8	23.34	8.37	7.71	0.00
Neurons, donor3	11655-122E8	22.20	9.87	14.80	0.00
Neutrophils, donor1	11233-116C9	205.09	51.04	52.90	0.93
Neutrophils, donor2	11314-117C9	275.39	28.99	26.09	0.00
Neutrophils, donor3	11390-118C4	339.63	59.25	55.59	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	34.20	7.48	7.84	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	36.47	7.81	8.47	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	53.35	9.63	5.62	0.40
Olfactory epithelial cells, donor1	11933-125I7	42.81	8.12	7.16	0.28
Olfactory epithelial cells, donor2	11934-125I8	56.45	7.96	7.24	1.30
Olfactory epithelial cells, donor3	11935-125I9	30.53	6.13	5.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	31.46	5.84	6.14	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	29.49	9.03	6.62	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.34	6.59	2.98	0.00
Osteoblast - differentiated, donor2	11353-117H3	17.15	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	20.48	8.69	3.72	1.24
Osteoblast, donor1	11277-116H8	25.41	8.99	10.75	0.00
Osteoblast, donor2	11354-117H4	64.61	11.94	11.24	0.00
Osteoblast, donor3	11426-118G4	57.58	11.91	11.37	0.00
Pancreatic stromal cells, donor1	11249-116E7	52.56	7.92	6.32	0.25
Pericytes, donor1	11491-119E6	65.76	11.68	8.12	0.00
Pericytes, donor2	11571-120E5	52.52	8.60	5.43	0.00
Pericytes, donor3	11652-122E5	61.85	13.02	13.22	0.20
Perineurial Cells, donor1	11499-119F5	24.64	7.91	6.22	0.00
Perineurial Cells, donor2	11579-120F4	45.91	13.53	12.70	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	70.76	19.76	11.47	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	223.31	26.45	11.26	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	204.99	25.37	16.44	0.00
Placental Epithelial Cells, donor1	11278-116H9	43.29	10.04	5.74	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	11.09	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.74	8.44	6.87	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.67	2.53	3.16	0.00
Preadipocyte - breast, donor1	11467-119B9	7.32	3.75	2.25	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.36	3.26	1.96	0.00
Preadipocyte - breast, donor2	11328-117E5	14.63	4.28	3.38	0.00
Preadipocyte - omental, donor1	11468-119C1	14.60	3.94	5.01	0.00
Preadipocyte - omental, donor2	11329-117E6	12.22	3.93	3.49	0.00
Preadipocyte - omental, donor3	11403-118D8	18.05	4.87	5.59	0.00
Preadipocyte - perirenal, donor1	11469-119C2	42.32	5.91	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	47.91	15.66	9.83	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	130.51	20.36	19.48	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	81.74	18.90	12.77	0.17
Preadipocyte - visceral, donor1	11280-116I2	69.95	17.60	14.90	0.00
Preadipocyte - visceral, donor2	11357-117H7	59.36	13.35	13.35	0.92
Preadipocyte - visceral, donor3	11429-118G7	97.18	17.45	13.17	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	87.95	14.03	12.07	0.30
Prostate Epithelial Cells, donor2	11331-117E8	50.37	6.23	3.79	0.27
Prostate Epithelial Cells, donor3	11404-118D9	36.31	3.43	2.76	0.12
Prostate Stromal Cells, donor1	11254-116F3	67.32	13.21	15.15	0.34
Prostate Stromal Cells, donor2	11332-117E9	111.70	12.73	12.91	0.90
Prostate Stromal Cells, donor3	11405-118E1	57.35	10.32	8.45	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	89.79	9.12	8.76	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.32	5.34	5.61	0.21
Renal Epithelial Cells, donor1	11517-119H5	76.08	20.80	18.77	0.00
Renal Epithelial Cells, donor2	11597-120H4	56.91	15.65	11.38	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.23	6.88	8.68	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	8.85	8.17	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	46.36	9.84	8.62	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	77.70	9.77	11.54	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	54.57	11.31	3.99	0.67
Renal Mesangial Cells, donor1	11518-119H6	45.78	9.68	9.68	0.00
Renal Mesangial Cells, donor2	11598-120H5	38.25	11.29	3.76	0.00
Renal Mesangial Cells, donor3	11679-122H5	43.28	12.48	8.32	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	194.87	16.37	15.03	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	215.91	12.65	5.06	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	91.99	16.58	20.83	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	95.67	18.67	14.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.77	11.94	9.38	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	98.80	18.52	20.58	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.82	9.03	4.77	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	92.08	10.69	8.02	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	38.42	6.25	8.93	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	7.15	3.85	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	2.32	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.16	8.06	7.28	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	68.42	12.12	14.90	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	63.47	17.96	14.05	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	68.97	11.91	12.28	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	67.60	14.45	16.32	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	73.73	13.87	12.71	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	58.73	11.50	14.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	69.74	12.25	10.74	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.92	15.77	16.31	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	69.15	13.05	14.78	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	65.78	12.99	17.06	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	86.52	16.60	17.92	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.50	10.71	9.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.90	11.27	12.76	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	56.75	14.09	12.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	68.61	12.61	11.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	63.86	11.58	14.41	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.79	12.41	20.24	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	64.40	13.78	12.82	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	70.36	11.77	12.33	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	67.68	13.50	16.58	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	67.83	11.85	16.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.55	16.43	16.19	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	82.07	13.83	14.78	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	67.46	14.15	14.15	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	71.43	18.85	17.26	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	86.06	16.84	18.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	77.97	13.48	15.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	56.41	14.60	17.70	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	74.57	16.71	17.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	71.06	16.55	16.69	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.48	16.69	13.62	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	77.31	19.28	19.86	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	58.29	17.37	12.72	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	56.51	18.38	16.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	63.04	17.07	18.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.57	12.61	13.46	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.48	15.98	19.53	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	55.18	9.86	11.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	61.39	9.68	11.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.00	16.43	17.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	58.85	11.29	15.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.80	13.09	9.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	72.67	11.53	11.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.87	7.86	9.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	50.06	12.36	10.40	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	35.37	10.77	11.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	54.15	8.52	6.69	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.16	12.06	15.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	48.86	9.05	10.86	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	41.64	8.39	9.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.65	7.44	7.79	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	46.32	10.89	10.89	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	36.66	7.81	7.21	0.00
Schwann Cells, donor1	11498-119F4	110.40	17.11	12.04	0.56
Schwann Cells, donor2	11578-120F3	98.67	0.00	6.80	0.00
Schwann Cells, donor3	11659-122F3	53.24	8.33	10.52	0.88
Sebocyte, donor1	11220-116B5	131.46	10.96	8.76	0.00
Sebocyte, donor2	11301-117B5	131.43	7.35	9.19	0.46
Sebocyte, donor3	11378-118B1	92.96	4.74	7.21	0.41
Sertoli Cells, donor1	11255-116F4	44.73	8.28	6.63	0.00
Sertoli Cells, donor2	11333-117F1	22.59	11.30	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.07	6.77	4.93	0.00
Skeletal Muscle Cells, donor2	11358-117H8	16.63	4.34	2.89	0.00
Skeletal Muscle Cells, donor3	11430-118G8	80.26	11.70	13.38	0.00
Skeletal Muscle Cells, donor4	11451-119A2	139.34	26.55	19.01	0.94
Skeletal Muscle Cells, donor5	11455-119A6	114.60	26.31	23.93	0.45
Skeletal Muscle Cells, donor6	11459-119B1	231.47	21.85	19.39	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.66	13.36	12.98	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	76.48	15.41	11.70	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	146.24	22.32	23.81	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.58	9.01	8.26	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	32.57	7.24	12.30	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.01	7.98	4.13	0.41
Skin - palm, donor1	10286-104F7	13.43	13.43	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	60.55	3.32	4.47	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	66.86	4.28	3.12	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	30.30	5.28	3.75	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	44.31	3.52	6.19	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	61.11	3.81	5.07	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	31.93	3.45	4.05	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	35.80	8.95	5.25	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.46	4.00	4.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	5.29	11.17	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.30	8.40	8.40	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	67.34	9.45	9.84	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	40.95	16.22	9.27	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	51.04	13.01	6.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.16	5.99	6.25	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	54.08	9.31	9.75	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.97	5.38	5.12	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	44.28	9.12	10.09	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.67	12.99	7.97	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	53.96	13.38	10.68	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	85.08	17.89	11.71	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.01	7.00	7.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	37.63	16.92	11.87	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	36.72	7.63	9.54	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.06	10.77	10.32	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	69.95	15.93	12.48	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	93.41	16.37	14.27	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	60.63	14.08	12.37	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	7.55	5.39	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	80.39	12.25	8.37	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	99.35	21.85	16.39	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.25	9.74	6.44	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.01	6.84	7.15	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	96.71	13.43	10.01	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	52.53	10.26	4.23	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	148.36	21.99	28.35	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.63	7.46	5.19	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.24	10.77	10.14	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.68	7.36	8.88	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.40	12.97	8.74	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	14.25	5.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	6.46	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.11	13.02	11.16	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	38.88	5.55	12.12	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.83	11.60	8.46	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	48.38	10.91	9.44	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	53.90	14.50	14.91	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.24	10.74	9.81	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	25.33	9.93	9.21	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	74.96	12.49	9.69	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	41.37	14.48	9.59	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	50.03	8.24	7.97	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	47.09	8.97	10.31	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	155.71	8.10	10.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.14	9.30	9.30	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	51.04	16.13	11.71	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.38	6.14	5.56	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	32.46	4.66	4.86	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.97	5.02	4.50	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	2.60	2.60	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.40	5.75	6.11	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.28	5.11	7.38	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	72.87	3.54	7.09	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	4.83	2.54	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	31.15	2.80	3.59	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	7.52	7.94	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	4.58	5.04	0.00
Synoviocyte, donor1	11291-117A4	118.67	7.74	8.25	0.00
Synoviocyte, donor2	11368-117I9	29.84	6.70	7.71	0.00
Synoviocyte, donor3	11440-118H9	27.93	5.59	3.80	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	105.41	22.51	27.51	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	89.19	7.93	9.91	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	42.37	11.81	8.34	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	39.86	6.31	5.73	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	63.01	7.73	7.73	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	79.03	15.46	6.30	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	100.76	12.79	8.73	0.25
Urethra, donor2	10319-105A4	32.37	7.19	7.19	0.00
Urothelial Cells, donor1	11520-119H8	56.59	5.05	5.84	0.53
Urothelial Cells, donor2	11600-120H7	67.70	8.81	6.41	0.40
Urothelial Cells, donor3	11681-122H7	51.57	7.11	6.42	0.23
Urothelial cells, donor0	11216-116B1	26.75	8.69	3.57	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	113.89	24.02	11.57	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	121.52	15.73	8.58	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	86.25	15.06	11.64	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.55	13.08	7.58	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	59.85	12.20	8.13	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	99.96	17.70	8.33	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	86.27	27.53	6.42	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	84.90	14.61	10.95	0.00
Wilms' tumor cell line:G-401	10809-111A8	40.34	11.97	11.84	0.00
Wilms' tumor cell line:HFWT	10597-108E3	50.16	7.92	14.08	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	192.73	24.30	19.27	0.28
achilles tendon, donor2	10292-104G4	839.01	18.60	12.40	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	76.49	22.95	18.10	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.97	15.79	19.27	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.04	18.76	14.60	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	75.38	11.70	18.23	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	199.57	33.17	35.70	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	314.26	16.71	39.12	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	271.94	15.79	18.51	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	124.70	11.46	18.95	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	227.86	22.87	15.93	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	185.99	29.12	24.46	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	183.26	23.74	22.82	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	136.52	11.70	15.60	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	210.77	22.31	16.50	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	126.34	21.75	19.68	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	145.54	26.30	23.09	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	115.26	17.20	19.06	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	90.89	14.39	7.81	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	344.71	30.39	28.24	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	139.53	20.48	23.90	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	127.99	16.38	15.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	158.38	18.29	18.53	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	224.30	20.71	22.27	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	431.28	20.35	27.02	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	11.15	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	522.80	34.65	32.77	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	232.89	13.52	17.88	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	133.09	11.25	18.74	0.00
adenocarcinoma cell line:IM95m	10796-110I4	60.29	17.66	7.77	0.47
adipose tissue, adult, pool1	10010-101C1	17.99	8.22	5.12	0.00
adipose, donor1	10184-103D4	9.38	0.59	1.76	0.59
adipose, donor2	10185-103D5	32.44	4.46	3.24	0.00
adipose, donor3	10186-103D6	34.85	5.45	5.17	0.27
adipose, donor4	10187-103D7	38.14	5.20	5.20	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	68.81	5.52	10.57	0.16
adrenal gland, adult, pool1	10081-102A9	363.77	3.64	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	53.90	13.87	10.14	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	96.11	25.37	17.86	0.36
amniotic membrane cells, donor1	12235-129G3	12.06	2.32	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	24.34	7.10	3.38	0.34
amniotic membrane cells, donor3	12237-129G5	9.43	1.47	0.59	0.00
amygdala - adult, donor10196	10167-103B5	53.36	8.30	7.11	0.00
amygdala, adult, donor10252	10151-102I7	39.13	11.76	8.52	0.00
amygdala, newborn, donor10223	10360-105E9	35.50	5.49	5.81	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	43.04	1.91	1.78	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	292.99	26.03	28.24	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	49.44	13.03	11.02	0.00
aorta, adult, pool1	10052-101G7	16.67	4.31	1.37	0.20
appendix, adult	10189-103D9	71.80	11.26	6.21	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	77.04	16.51	11.69	0.00
artery, adult	10190-103E1	50.27	10.87	10.87	0.00
astrocytoma cell line:TM-31	10425-106D2	26.22	4.35	6.08	0.14
b cell line:RPMI1788	10427-106D4	60.67	13.38	18.44	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	66.31	9.43	8.05	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	126.32	7.05	8.43	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	102.10	5.86	3.68	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	85.00	15.66	13.98	1.12
bladder, adult, pool1	10011-101C2	28.46	7.17	5.00	0.00
blood, adult, pool1	10053-101G8	24.36	15.50	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	5.14	5.14	0.00
bone marrow, adult	10192-103E3	58.71	12.15	5.40	1.35
brain, adult, donor1	10084-102B3	84.06	17.43	15.38	0.00
brain, adult, pool1	10012-101C3	40.98	9.80	10.58	0.22
brain, fetal, pool1	10085-102B4	34.73	13.36	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.32	7.60	5.95	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.56	10.98	6.87	0.00
breast, adult, donor1	10080-102A8	37.25	15.78	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	220.66	21.72	8.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.05	6.18	4.64	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.48	1.84	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	46.96	15.74	9.44	0.00
carcinoid cell line:NCI-H1770	10703-109H1	79.93	15.99	19.28	0.47
carcinoid cell line:NCI-H727	10735-110B6	59.07	9.19	8.86	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	47.22	16.16	14.26	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.43	30.61	15.70	0.27
caudate nucleus - adult, donor10196	10177-103C6	80.59	4.61	8.06	0.00
caudate nucleus, adult, donor10252	10164-103B2	39.99	7.53	7.36	0.17
caudate nucleus, adult, donor10258	10379-105H1	35.91	11.46	8.41	0.00
caudate nucleus, newborn, donor10223	10354-105E3	46.88	5.86	3.66	0.37
cerebellum - adult, donor10196	10173-103C2	46.61	11.65	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	28.82	7.90	7.26	0.00
cerebellum, adult, pool1	10083-102B2	25.53	8.62	7.59	0.00
cerebellum, newborn, donor10223	10357-105E6	52.31	5.81	1.66	0.00
cerebral meninges, adult	10188-103D8	30.00	9.58	8.32	0.00
cerebrospinal fluid, donor2	10294-104G6	229.50	17.54	11.69	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.34	31.34	14.95	0.14
cervical cancer cell line:ME-180	10553-107I4	154.78	12.76	13.26	0.17
cervix, adult, pool1	10013-101C4	33.49	3.99	3.67	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	51.69	9.20	11.57	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	2.61	5.23	0.00
choriocarcinoma cell line:BeWo	10423-106C9	75.56	8.45	9.82	0.00
choriocarcinoma cell line:SCH	10785-110H2	59.02	3.57	1.36	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	168.63	3.79	6.40	0.00
chorionic membrane cells, donor1	12238-129G6	37.04	2.56	2.28	0.28
chorionic membrane cells, donor2	12239-129G7	23.57	5.57	4.97	0.00
chorionic membrane cells, donor3	12240-129G8	45.06	2.20	3.85	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	138.34	21.21	10.10	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	107.58	16.71	17.10	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	114.89	22.81	13.30	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	142.78	21.83	25.68	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	148.03	22.98	32.90	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	152.50	17.92	25.25	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	131.92	36.51	39.75	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	72.98	16.16	13.29	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	130.29	5.94	7.31	0.69
clear cell carcinoma cell line:TEN	10636-108I6	49.45	7.11	5.21	0.35
colon carcinoma cell line:CACO-2	10513-107D9	123.55	25.44	18.49	0.18
colon carcinoma cell line:COLO-320	10420-106C6	91.98	12.92	15.58	0.38
colon, adult, donor1	10082-102B1	59.50	20.23	15.47	2.38
colon, adult, pool1	10014-101C5	31.84	13.51	7.17	0.00
colon, fetal, donor1	10070-101I7	53.15	13.60	5.56	0.00
common myeloid progenitor CMP, donor1	12130-128D6	215.43	27.50	41.25	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	69.26	5.52	3.40	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	103.99	14.04	15.40	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	110.69	12.83	12.83	0.14
corpus callosum, adult, pool1	10042-101F6	135.88	15.15	12.49	0.00
cruciate ligament, donor2	10295-104G7	392.27	4.05	6.48	0.81
diaphragm, fetal, donor1	10069-101I6	56.98	13.64	12.84	0.00
diencephalon, adult	10193-103E4	89.76	11.52	8.64	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	143.28	28.24	20.44	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.21	13.08	8.98	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	51.76	6.50	7.22	0.00
ductus deferens, adult	10196-103E7	47.34	7.97	6.48	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	66.25	17.28	5.76	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	73.56	13.24	4.41	0.00
dura mater, adult, donor1	10041-101F5	31.88	16.19	8.42	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	191.43	18.88	25.09	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	101.88	23.64	30.09	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	326.81	22.20	25.90	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	240.65	13.62	16.95	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	335.92	18.22	21.92	0.31
embryonic pancreas cell line:2C6	10603-108E9	321.80	21.02	15.76	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	45.59	4.36	6.03	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.29	3.44	2.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	57.89	6.43	4.34	0.32
epidermoid carcinoma cell line:A431	10426-106D3	68.47	14.23	10.34	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	128.57	11.88	14.63	0.11
epididymis, adult	10197-103E8	25.12	7.33	3.77	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	4.61	1.95	1.77	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	72.75	9.44	11.40	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	144.94	18.87	16.12	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	108.26	17.91	16.53	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	153.26	18.60	19.72	0.67
esophagus, adult, pool1	10015-101C6	25.70	6.80	4.35	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	10.90	2.50	3.01	0.00
eye - muscle inferior rectus, donor1	10272-104E2	108.66	12.07	12.07	0.00
eye - muscle lateral, donor2	10298-104H1	202.00	18.94	12.63	0.00
eye - muscle medial, donor2	10299-104H2	84.83	14.88	13.39	0.00
eye - muscle superior, donor2	10297-104G9	228.15	8.03	8.03	0.00
eye - vitreous humor, donor1	10268-104D7	429.93	14.57	10.20	0.00
eye, fetal, donor1	10054-101G9	27.71	5.08	4.32	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	77.96	6.92	6.41	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	171.42	9.02	13.30	0.00
frontal lobe, adult, pool1	10040-101F4	33.96	15.20	10.41	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	28.52	8.41	3.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	71.32	3.57	5.76	0.09
gall bladder, adult	10198-103E9	29.70	7.24	7.48	0.48
gamma delta positive T cells, donor1	11937-126A2	19.33	6.98	3.76	0.00
gamma delta positive T cells, donor2	11938-126A3	26.14	9.34	5.98	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.67	2.96	2.11	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	84.52	11.41	10.83	0.19
gastric cancer cell line:AZ521	10549-107H9	31.48	5.08	12.95	0.00
gastric cancer cell line:GSS	10560-108A2	98.84	10.98	9.15	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.14	7.08	5.25	0.00
giant cell carcinoma cell line:LU65	10487-107B1	110.61	21.34	20.65	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	47.45	3.78	2.80	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	115.48	9.48	6.73	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	33.67	12.77	8.44	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	32.58	9.41	10.39	0.00
glioblastoma cell line:T98G	10485-107A8	73.29	9.16	8.17	0.00
glioma cell line:GI-1	10413-106B8	29.87	8.20	6.15	0.00
globus pallidus - adult, donor10196	10175-103C4	119.54	10.20	6.56	0.00
globus pallidus, adult, donor10252	10161-103A8	100.57	15.87	10.25	0.24
globus pallidus, adult, donor10258	10367-105F7	65.72	4.11	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	115.64	9.06	7.46	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	362.18	95.44	90.54	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	131.14	21.86	54.64	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	172.48	5.23	36.59	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.96	5.44	5.12	0.00
hIPS +CCl2, biol_rep1	14383-156B9	41.32	6.89	5.51	0.00
hIPS +CCl2, biol_rep2	14384-156C1	46.18	8.69	8.23	0.00
hIPS +CCl2, biol_rep3	14385-156C2	57.97	1.93	7.73	0.00
hIPS, biol_rep1	14380-156B6	60.37	1.44	7.19	0.00
hIPS, biol_rep2	14381-156B7	67.22	4.80	4.12	0.00
hIPS, biol_rep3	14382-156B8	90.48	8.83	9.93	0.00
hairy cell leukemia cell line:Mo	10712-109I1	73.85	6.32	9.48	0.00
heart - mitral valve, adult	10205-103F7	45.44	12.86	11.06	0.30
heart - pulmonic valve, adult	10206-103F8	62.49	18.56	14.12	0.00
heart - tricuspid valve, adult	10207-103F9	86.59	11.66	8.33	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	67.54	13.26	11.22	0.41
heart, adult, diseased, donor1	10051-101G6	107.31	16.61	15.76	0.00
heart, adult, pool1	10016-101C7	84.63	22.31	22.54	0.00
heart, fetal, pool1	10046-101G1	98.98	18.69	17.04	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	5.86	3.70	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	152.21	8.32	5.95	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	277.12	25.08	25.41	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	294.09	28.64	30.22	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	280.62	26.27	28.70	1.01
hepatoma cell line:Li-7	10484-107A7	91.53	20.46	18.91	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	156.38	23.62	24.72	0.40
hippocampus - adult, donor10196	10169-103B7	59.62	14.19	10.41	0.00
hippocampus, adult, donor10252	10153-102I9	45.11	12.04	8.16	0.00
hippocampus, adult, donor10258	10374-105G5	41.33	4.48	5.98	0.00
hippocampus, newborn, donor10223	10363-105F3	39.13	6.70	8.81	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	75.07	3.05	7.93	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	98.18	7.07	13.35	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	79.72	9.14	13.46	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	7.33	6.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	37.44	10.33	11.62	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	33.79	7.97	11.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	35.91	4.67	7.30	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	65.71	10.99	10.77	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	56.30	10.43	10.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.25	12.08	14.92	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	77.63	18.48	17.36	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	70.02	11.45	16.83	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.66	5.95	9.55	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.64	5.90	14.74	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	40.15	6.98	6.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.22	11.65	12.79	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.50	6.98	10.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	19.49	4.00	3.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	25.43	4.33	7.72	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	23.19	7.28	6.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.00	4.70	6.26	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	28.58	8.49	8.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.64	5.81	9.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	6.88	7.17	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	114.36	12.19	19.40	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	130.09	9.13	15.69	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	80.03	3.27	10.62	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	36.97	7.39	15.14	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	51.95	8.87	11.09	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.37	6.96	9.99	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	46.02	7.24	7.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	48.48	4.65	5.31	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.32	6.16	7.70	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	48.83	9.20	10.99	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	45.43	10.60	8.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	47.05	6.72	7.73	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	105.30	10.38	19.08	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	96.71	9.80	13.82	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	116.10	12.68	18.54	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	35.45	9.78	9.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	0.00	13.01	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.83	4.96	5.30	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	68.41	8.76	10.40	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.98	6.51	7.96	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.06	7.47	8.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	62.06	5.97	11.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.87	8.94	14.49	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	42.03	6.47	10.78	0.27
immature langerhans cells, donor1	11904-125F5	567.83	14.77	12.35	0.48
immature langerhans cells, donor2	11905-125F6	605.98	19.01	12.67	3.96
insula, adult, pool1	10039-101F3	26.88	14.38	13.53	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	175.91	24.06	13.98	0.00
kidney, adult, pool1	10017-101C8	66.68	15.22	11.01	0.10
kidney, fetal, pool1	10045-101F9	54.04	11.67	8.06	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	77.83	10.79	12.78	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	146.54	10.64	10.23	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.01	3.49	4.77	0.00
left atrium, adult, donor1	10079-102A7	63.75	22.34	20.70	0.54
left ventricle, adult, donor1	10078-102A6	84.95	14.16	10.62	0.51
leiomyoblastoma cell line:G-402	10721-110A1	50.62	12.04	9.58	0.00
leiomyoma cell line:10964C	10569-108B2	43.47	11.86	6.11	0.72
leiomyoma cell line:15242A	10570-108B3	47.28	9.78	4.89	0.54
leiomyoma cell line:15425	10571-108B4	45.16	7.53	4.86	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	23.00	15.68	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	85.24	12.28	13.58	0.00
liposarcoma cell line:KMLS-1	10782-110G8	52.49	5.00	3.75	0.16
liposarcoma cell line:SW 872	10726-110A6	43.13	6.94	7.80	0.00
liver, adult, pool1	10018-101C9	186.37	29.50	25.61	0.16
liver, fetal, pool1	10086-102B5	61.15	20.70	10.35	0.00
locus coeruleus - adult, donor10196	10182-103D2	107.91	17.35	15.46	0.00
locus coeruleus, adult, donor10252	10165-103B3	86.19	11.07	10.70	0.18
locus coeruleus, adult, donor10258	10375-105G6	159.41	14.11	17.21	0.28
locus coeruleus, newborn, donor10223	10362-105F2	63.09	3.79	2.94	0.00
lung adenocarcinoma cell line:A549	10499-107C4	40.55	3.04	2.77	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	84.11	8.27	7.58	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	58.66	3.82	4.35	0.13
lung, adult, pool1	10019-101D1	23.63	7.21	3.19	0.00
lung, fetal, donor1	10068-101I5	27.40	4.28	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	30.24	3.21	6.42	0.00
lymph node, adult, donor1	10077-102A5	39.29	14.67	11.83	1.89
lymphangiectasia cell line:DS-1	10727-110A7	189.59	8.77	16.00	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	75.46	9.06	17.05	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	124.03	11.04	6.80	0.00
mature adipocyte, donor1	12231-129F8	94.13	10.21	7.99	0.00
mature adipocyte, donor2	12232-129F9	77.62	11.00	6.64	0.00
mature adipocyte, donor3	12233-129G1	92.22	14.93	10.19	0.00
mature adipocyte, donor4	12234-129G2	74.49	14.21	6.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	53.85	3.34	5.96	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	9.02	14.66	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	47.63	12.14	10.67	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	33.99	8.58	10.48	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	1.71	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	41.34	11.48	10.97	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	51.78	7.85	9.97	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	5.78	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.92	2.51	3.95	0.00
medulla oblongata - adult, donor10196	10174-103C3	125.25	11.03	13.63	0.00
medulla oblongata, adult, donor10252	10155-103A2	78.95	11.92	11.15	0.15
medulla oblongata, adult, pool1	10038-101F2	72.08	14.20	14.86	0.00
medulla oblongata, newborn, donor10223	10361-105F1	129.15	9.37	9.37	0.69
medulloblastoma cell line:D283 Med	10838-111E1	62.00	20.37	20.81	0.44
medulloblastoma cell line:ONS-76	10759-110E3	30.81	5.26	7.09	0.00
melanoma cell line:COLO 679	10514-107E1	94.15	7.04	13.37	0.14
melanoma cell line:G-361	10465-106H6	32.03	4.34	3.80	0.27
meningioma cell line:HKBMM	10691-109F7	49.03	3.98	4.16	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	100.45	28.20	26.43	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	40.44	12.44	10.37	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	59.99	16.42	12.89	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	27.09	6.73	6.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	54.66	8.70	5.38	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	32.87	10.96	4.92	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	50.07	16.75	8.09	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	68.71	9.02	6.25	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.85	8.58	6.01	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	53.37	11.50	8.17	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.58	7.83	6.23	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	58.47	11.34	9.32	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	69.00	9.25	5.26	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	113.30	11.20	9.22	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.38	12.04	7.89	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.37	8.03	3.84	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.34	6.12	3.06	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.23	3.95	3.24	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	26.38	7.55	4.76	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	35.79	5.47	7.98	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.51	4.20	6.71	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	81.44	8.82	9.41	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.72	12.95	6.48	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.49	8.47	4.42	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.34	5.72	7.73	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	25.68	10.53	5.47	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.66	5.94	3.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.60	3.07	6.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.63	4.19	3.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.19	5.55	5.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.12	5.65	5.88	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.03	4.40	4.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.43	6.68	2.75	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.61	6.49	5.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.52	4.90	7.21	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	23.87	4.02	4.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.99	3.12	5.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	4.40	10.27	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.15	3.36	3.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	4.50	4.50	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.32	6.44	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.51	4.87	4.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	1.45	10.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	8.53	5.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	6.54	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.49	3.50	4.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	4.20	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	5.96	4.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.75	4.15	5.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	6.09	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.97	5.70	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.42	10.00	3.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	6.45	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	11.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.75	6.11	3.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	5.56	6.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	3.54	7.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.86	5.92	7.48	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	32.08	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	140.74	4.73	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	166.92	7.70	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	154.89	8.95	8.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	240.97	27.71	27.21	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	259.07	20.19	19.07	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	227.71	20.35	22.26	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	460.21	51.58	42.31	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	501.54	50.15	37.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	486.55	40.55	40.55	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	194.20	39.45	30.95	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	212.39	40.67	36.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	179.56	44.48	23.89	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	116.08	11.91	11.71	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	145.37	11.68	12.01	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	160.94	22.41	15.28	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	1.55	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	32.60	4.49	5.67	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	84.10	19.92	13.21	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	230.77	21.37	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	101.00	5.45	7.60	0.31
mesothelioma cell line:Mero-25	10850-111F4	136.63	9.99	9.31	0.45
mesothelioma cell line:Mero-41	10851-111F5	66.74	12.22	7.82	0.49
mesothelioma cell line:Mero-48a	10852-111F6	39.64	6.20	5.54	0.22
mesothelioma cell line:Mero-82	10853-111F7	83.05	7.88	7.62	0.26
mesothelioma cell line:Mero-83	10854-111F8	48.85	7.15	4.26	0.00
mesothelioma cell line:Mero-84	10855-111F9	85.94	14.16	11.12	0.76
mesothelioma cell line:Mero-95	10856-111G1	76.19	9.94	8.28	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	200.77	17.06	14.91	0.33
mesothelioma cell line:NCI-H226	10846-111E9	210.31	13.76	13.03	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	56.88	11.10	8.54	0.00
mesothelioma cell line:NCI-H28	10845-111E8	102.04	16.54	15.01	0.25
mesothelioma cell line:No36	10857-111G2	106.02	22.83	18.92	0.33
mesothelioma cell line:ONE58	10858-111G3	432.71	24.66	22.22	1.90
migratory langerhans cells, donor1	11901-125F2	62.57	7.68	3.26	0.19
migratory langerhans cells, donor2	11902-125F3	90.73	5.50	3.54	0.00
migratory langerhans cells, donor3	11903-125F4	53.84	6.82	8.08	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	132.88	11.10	15.67	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	144.33	19.71	24.58	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	214.46	14.74	13.36	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	92.29	9.51	7.23	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	137.12	19.96	24.95	0.18
myeloma cell line:PCM6	10474-106I6	20.16	2.77	2.77	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	70.01	12.17	5.58	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	67.86	9.02	8.04	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	62.95	7.13	5.57	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	56.99	5.07	5.15	0.15
nasal epithelial cells, donor2	12227-129F4	58.51	8.83	6.62	0.00
neuroblastoma cell line:CHP-134	10508-107D4	20.02	7.82	6.44	0.00
neuroblastoma cell line:NB-1	10539-107G8	33.86	24.51	20.39	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	73.60	8.01	13.08	0.21
neuroblastoma cell line:NH-12	10555-107I6	74.35	12.30	11.93	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	38.91	12.57	8.07	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	49.57	19.96	9.82	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	83.32	15.70	13.69	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	61.03	19.07	12.72	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	36.46	7.98	6.39	0.27
neutrophil PMN, donor1	12133-128D9	133.87	0.00	29.75	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	68.66	17.59	11.84	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	80.05	24.02	18.41	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.36	5.45	1.60	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.72	6.57	3.68	0.79
nucleus accumbens, adult, pool1	10037-101F1	37.96	14.25	10.12	0.00
occipital cortex - adult, donor10196	10172-103C1	61.81	14.42	8.24	0.00
occipital cortex, adult, donor10252	10163-103B1	69.77	12.61	10.47	0.27
occipital cortex, newborn, donor10223	10355-105E4	41.85	4.73	5.46	0.00
occipital lobe, adult, donor1	10076-102A4	60.09	20.20	18.11	0.00
occipital lobe, fetal, donor1	10073-102A1	18.88	9.44	7.29	0.00
occipital pole, adult, pool1	10036-101E9	45.73	16.16	13.17	0.08
olfactory region, adult	10195-103E6	50.25	13.37	10.70	0.19
optic nerve, donor1	10277-104E7	198.10	10.01	16.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	86.80	9.00	9.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	393.89	44.79	59.35	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	68.24	6.10	2.88	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	93.91	9.47	9.36	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	33.51	3.53	3.82	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	65.40	10.28	12.15	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	57.04	12.30	11.24	0.00
ovary, adult, pool1	10020-101D2	19.83	3.93	3.41	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	124.84	4.40	7.88	0.00
pancreas, adult, donor1	10049-101G4	134.51	18.81	10.35	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	62.34	5.87	6.71	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	58.09	7.50	8.69	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.65	5.13	2.81	0.00
paracentral gyrus, adult, pool1	10035-101E8	35.33	17.85	13.64	0.09
parietal cortex, adult, donor10258	10373-105G4	25.69	7.34	4.40	0.00
parietal lobe - adult, donor10196	10171-103B9	48.91	13.17	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	43.61	12.54	9.12	0.00
parietal lobe, adult, pool1	10034-101E7	43.71	15.86	13.83	0.00
parietal lobe, fetal, donor1	10072-101I9	12.61	7.76	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	35.52	5.23	4.49	0.00
parotid gland, adult	10199-103F1	32.68	8.02	7.40	1.23
penis, adult	10200-103F2	32.23	6.45	8.06	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.34	2.97	1.67	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.70	7.58	4.23	0.00
pineal gland - adult, donor10196	10179-103C8	14.84	0.65	3.23	0.00
pineal gland, adult, donor10252	10160-103A7	17.77	0.59	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	14.42	1.25	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	28.33	5.06	8.09	0.00
pituitary gland, adult, donor10252	10162-103A9	26.06	3.13	5.21	0.00
pituitary gland, adult, donor10258	10378-105G9	33.20	0.85	1.70	0.00
placenta, adult, pool1	10021-101D3	37.73	4.52	3.87	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	130.84	10.86	17.88	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.30	3.74	3.42	0.00
pons, adult, pool1	10033-101E6	54.91	16.70	18.07	0.00
postcentral gyrus, adult, pool1	10032-101E5	40.71	17.44	17.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	545.85	43.92	71.11	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	115.67	22.03	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	11.74	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	71.96	9.76	5.54	0.15
prostate cancer cell line:PC-3	10439-106E7	288.41	65.52	69.15	0.36
prostate, adult, pool1	10022-101D4	20.86	4.72	2.99	0.09
putamen, adult, donor10196	10176-103C5	39.66	8.50	10.62	0.24
putamen, adult, donor10252	10152-102I8	68.63	9.80	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	41.53	1.09	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.89	8.21	7.25	0.00
putamen, newborn, donor10223	10365-105F5	52.48	2.25	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	49.75	4.65	4.36	0.00
rectum, fetal, donor1	10067-101I4	44.51	5.56	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.44	7.00	4.24	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	40.18	3.31	3.73	0.41
retina, adult, pool1	10030-101E3	29.32	7.75	5.86	0.00
retinoblastoma cell line:Y79	10475-106I7	45.47	27.02	17.67	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	43.77	5.29	6.02	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.24	7.87	5.91	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	39.41	12.13	4.55	0.00
salivary acinar cells, donor1	11771-123I7	41.76	8.74	7.93	0.16
salivary acinar cells, donor2	11772-123I8	24.65	4.82	2.89	0.28
salivary acinar cells, donor3	11773-123I9	135.72	4.63	3.31	0.00
salivary gland, adult, pool1	10093-102C3	49.19	8.01	2.86	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.25	22.17	16.95	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.72	16.93	17.52	0.24
seminal vesicle, adult	10201-103F3	85.71	10.05	5.29	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	75.79	7.04	4.37	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	97.38	6.54	4.28	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	59.21	11.04	5.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	69.18	4.30	4.16	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	85.99	16.80	11.61	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	82.19	23.35	8.77	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	144.70	17.02	23.41	0.71
skeletal muscle, adult, pool1	10023-101D5	68.24	14.51	16.19	0.36
skeletal muscle, fetal, donor1	10066-101I3	27.14	8.04	11.06	0.00
skin, adult, donor1	10074-102A2	81.42	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	49.24	10.10	5.05	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	138.75	27.02	18.68	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.89	14.81	13.24	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.33	10.22	15.23	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	43.35	20.60	12.69	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	76.40	8.53	11.74	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	95.45	6.32	8.50	0.22
small intestine, adult, pool1	10024-101D6	32.73	14.21	6.69	0.12
small intestine, fetal, donor1	10064-101I1	42.51	9.58	7.86	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	92.32	22.57	15.39	3.08
smooth muscle, adult, pool1	10048-101G3	23.00	10.34	4.39	0.26
somatostatinoma cell line:QGP-1	10781-110G7	43.69	24.93	8.84	0.27
spinal cord - adult, donor10196	10181-103D1	151.41	8.95	10.32	0.23
spinal cord, adult, donor10252	10159-103A6	52.04	14.59	7.89	0.00
spinal cord, adult, donor10258	10369-105F9	114.15	4.15	4.15	0.69
spinal cord, fetal, donor1	10056-101H2	87.21	14.03	18.30	0.00
spinal cord, newborn, donor10223	10359-105E8	60.62	5.51	4.13	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	47.49	8.07	7.32	0.00
spleen, adult, pool1	10025-101D7	44.60	10.90	8.48	0.11
spleen, fetal, pool1	10044-101F8	59.43	8.82	6.75	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	108.27	15.32	17.49	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.67	4.75	4.18	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	41.58	11.18	10.83	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	376.86	7.04	4.30	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	81.72	16.55	14.18	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	163.93	2.54	3.81	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	70.65	9.31	10.58	0.00
stomach, fetal, donor1	10062-101H8	83.30	16.02	13.88	0.00
submaxillary gland, adult	10202-103F4	48.42	9.11	4.56	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	105.31	13.09	7.69	0.62
substantia nigra, adult, donor10258	10371-105G2	132.93	6.21	11.38	0.52
substantia nigra, newborn, donor10223	10358-105E7	123.65	4.95	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	105.92	23.16	25.68	0.23
temporal lobe, adult, pool1	10031-101E4	43.49	21.02	13.73	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	9.97	9.26	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	27.69	8.79	3.52	0.00
tenocyte, donor1	11763-123H8	53.41	12.22	7.68	0.00
tenocyte, donor2	11765-123I1	73.25	4.20	8.77	0.00
tenocyte, donor3	11768-123I4	34.84	8.90	6.30	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	132.74	11.39	12.58	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	53.95	9.09	7.86	0.00
teratocarcinoma cell line:PA-1	10807-111A6	34.10	7.44	7.59	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	73.50	15.36	11.04	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	41.98	5.29	4.16	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	48.10	12.43	6.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	67.42	3.26	3.58	0.00
testis, adult, pool1	10026-101D8	51.22	13.64	16.75	0.00
testis, adult, pool2	10096-102C6	108.71	20.30	18.95	0.45
thalamus - adult, donor10196	10168-103B6	174.43	7.73	13.25	0.00
thalamus, adult, donor10252	10154-103A1	87.21	9.85	6.72	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	153.96	0.00	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	176.88	15.15	16.96	0.33
thalamus, newborn, donor10223	10366-105F6	44.30	2.30	6.90	0.00
throat, adult	10209-103G2	61.67	9.74	7.24	0.75
throat, fetal, donor1	10061-101H7	28.03	7.01	4.57	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	129.57	42.13	29.21	0.79
thymus, adult, pool1	10027-101D9	27.84	7.16	6.86	0.00
thymus, fetal, pool1	10043-101F7	30.86	6.13	5.51	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	239.99	12.10	11.04	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	31.15	4.61	6.57	0.00
thyroid, adult, pool1	10028-101E1	41.99	3.83	4.39	0.00
thyroid, fetal, donor1	10060-101H6	65.12	5.54	5.54	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	107.79	6.16	6.16	0.00
tongue, adult	10203-103F5	251.42	12.33	13.26	1.16
tongue, fetal, donor1	10059-101H5	78.42	14.19	9.85	0.39
tonsil, adult, pool1	10047-101G2	85.35	9.42	8.51	0.00
trachea, adult, pool1	10029-101E2	36.89	6.71	6.30	0.00
trachea, fetal, donor1	10058-101H4	40.39	6.92	5.39	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	59.52	15.23	11.34	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	45.80	9.52	9.02	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	106.86	14.42	14.57	0.16
tridermal teratoma cell line:HGRT	10694-109G1	41.86	7.61	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.32	6.69	3.64	0.00
umbilical cord, fetal, donor1	10057-101H3	35.47	0.00	4.17	0.00
uterus, adult, pool1	10100-102D1	15.02	4.78	1.88	0.00
uterus, fetal, donor1	10055-101H1	48.63	7.68	5.63	0.00
vagina, adult	10204-103F6	34.25	5.82	2.58	0.00
vein, adult	10191-103E2	36.17	7.89	8.11	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	83.32	10.68	13.35	0.27